Efficacy of preexposure prophylaxis with monoclonal-antibody tixagevimab-cilgavimab against emerging SARS-CoV-2 resistant variants in patients with chronic lymphocytic leukemia

Conclusion Efficacy of preexposure prophylaxis with TGM/CGM in patients with CLL is significantly reduced in era of Omicron and its sublineages BA2, BA4 and BA5.PMID:38471491 | DOI:10.1159/000537690

Source: Acta Haematologica - March 12, 2024 Category: Hematology Authors: Ohad Benjamini Tamar Tadmor Abraham Avigdor Rotem Gershon Limor Kliker Florin Fares Nofar Atari Ilana Laevsky Bayan Abd Elkader Tammy Hod Orit Golan-Shany Michal Mandelboim Galia Rahav Source Type: research